CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

Glocusent’s Bookmark Style Reading Light is the perfect gift for those who burn the midnight oil reading. The clip-on USB ...

Chances are, at some time in the last few days, you have seen the iconic NASA logo – in the media universe, on a passing car, ...

The idea of a species is fundamental to the way that many people understand the structure of life on Earth. But ask 10 ...

Better not shout, better not pout! Pull out your cutest matching family PJs and cheerful Advent Calendars, because before you ...

Motherhood, philanthropy, and entrepreneurship make up Melissa Lim Mae Lyn’s real-life fairytale. Hers is a journey of design ...

In the US presidential campaign and beyond, politics is taking a heavy psychological toll. Can we raise the tone?

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

Generative AI for Everyone: Gain hands-on experience with AI projects to apply your knowledge. In today's world, STEM ...

The shortage of skilled workers is also no longer what it used to be: it is smaller than before, according to IW's MINT ...

Legal scholar Dr. Joshua Weiser offers a framework for stem cell research in his book, "Embryonic Stem Cells and the Law." ...